Bibliografia UJ CM

1/20
Christine Mauz-Korholz, Judith Landman-Parker, Ana Fernandez-Teijeiro, Andishe Attarbaschi, Walentyna Balwierz, Jorg M. Bartelt, Auke Beishuizen, Sabah Boudjemaa, Michaela Cepelova, Francesco Ceppi, Alexander Claviez, Stephen Daw, Karin Dieckmann, Alexander Fossa, Stefan Gattenlohner, Thomas Georgi, Lisa L. Hjalgrim, Andrea Hraskova, Jonas Karlen, Lars Kurch, Thierry Leblanc, Georg Mann, Francoise Montravers, Jane Pears, Tanja Pelz, Vladan Rajic, Alan D. Ramsay, Dietrich Stoevesandt, Anne Uyttebroeck, Dirk Vordermark, Dieter Korholz, Dirk Hasenclever, William H. Wallace, Regine Kluge.
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1) : a titration study
Lancet. Oncology
2023 : Vol. 24, nr 3, s. 252-261, il., bibliogr. 26 poz., sum.
Autor korespondencyjny: William H. Wallace.
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 1470-2045
e-ISSN: 1474-5488
AZ
ORG
AIF
IF: 51.100
Adres url:
Streszczenie w PubMed:
2/20
Darya Kizub, Nelya Melnitchouk, Andriy Beznosenko, Galyna Shabat, Solomiia Semeniv, Leticia Nogueira, Patricia J. Watson, Kim Berg, Edward J. Trapido, Zelde Espinel, James M. Shultz.
Resilience and perseverance under siege : providing cancer care during the invasion of Ukraine
Lancet. Oncology
2022 : Vol. 23, nr 5, s. 597-583, il., bibliogr. 21 poz.
Autor korespondencyjny: James M. Shultz
p-ISSN: 1470-2045
e-ISSN: 1474-5488
AZ
POG
AIF
IF: 51.100
Adres url:
Streszczenie w PubMed:
3/20
Christine Mauz-Korholz, Judith Landman-Parker, Walentyna Balwierz, Roland A. Ammann, Richard A. Anderson, Andishe Attarbaschi, Jorg M. Bartelt, Auke Beishuizen, Sabah Boudjemaa, Michaela Cepelova, Alexander Claviez, Stephen Daw, Karin Dieckmann, Ana Fernandez-Teijeiro, Alexander Fossa, Stefan Gattenlohner, Thomas Georgi, Lisa L. Hjalgrim, Andrea Hraskova, Jonas Karlen, Regine Kluge, Lars Kurch, Thiery Leblanc, Georg Mann, Francoise Montravers, Jean Pears, Tanja Pelz, Vladan Rajic, Alan D. Ramsay, Dietrich Stoevesandt, Anne Uyttebroeck, Dirk Vordermark, Dieter Korholz, Dirk Hasenclever, William Hamish Wallace.
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1) : a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.
Lancet. Oncology
2022 : Vol. 23, nr 1, s. 125-137, il., bibliogr. 30 poz., sum.
Autor korespondencyjny: William Hamish Wallace.
Open Access Creative Commons Attribution License CC-BY 4.0.
Equal contribution: Christine Mauz-Korholz, Judith Landman-Parker, Walentyna Balwierz
p-ISSN: 1470-2045
e-ISSN: 1474-5488
AZ
ORG
AIF
IF: 51.100
Adres url:
Streszczenie w PubMed:
4/20
The global burden of adolescent and young adult cancer in 2019 : a systematic analysis for the Global Burden of Disease Study 2019.
Lancet. Oncology
2022 : Vol. 23, nr 1, s. 27-52, il., bibliogr. 35 poz., sum.
Autor korespondencyjny: Elysia Alvarez.
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 1470-2045
e-ISSN: 1474-5488
AZ
IF: 51.100
Adres url:
Streszczenie w PubMed:
5/20
Constantine S. Tam, Jennifer R. Brown, Brad S. Kah, Paolo Ghia, Giannopoulo Giannopoulos, Wojciech Jurczak, Martin imkovič, Mazyar Shadman, Anders Österborg, Luca Laurenti, Patricia Walker, Stephen Opat, Henry Chan, Hanna Ciepluch, Richard Greil, Monica Tani, Marek Trneny, Danielle M. Brander, Ian W. Flinn, Sebastian Grosicki, Emma Verner, Alessandra Tedeschi, Jianyong Li, Tian Tian, Lei Zhou, Carol Marimpietri, Jason C. Paik, Aileen Cohe, Jane Huang, Tadeusz Robak, Peter Hillmen.
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA) : a randomised, controlled, phase 3 trial.
Lancet. Oncology
2022 : Vol. 23, nr 8, s. 1031-1043, il., bibliogr. 31 poz., sum.
Autor korespondencyjny: Tadeusz Robak, Peter Hillmen.
p-ISSN: 1470-2045
e-ISSN: 1474-5488
AZ
ORG
AIF
IF: 51.100
Adres url:
Streszczenie w PubMed:
6/20
Matthew J. Matasar, Marcelo Capra, Muhit Özcan, Fangfang Lv, Wei Li, Eduardo Yanez, Katya Sapunarova, Tongyu Lin, Jie Jin, Wojciech Jurczak, Aryan Hamed, Ming-Chung Wang, Ross Baker, Igor Bondarenko, Qingyuan Zhang, Jifeng Feng, Klaus Geissler, Mihaela Lazaroiu, Guray Saydam, Árpád Szomor, Krimo Bouabdallah, Rinat Galiulin, Toshiki Uchida, Lidia Mongay Soler, Anjun Cao, Florian Hiemeyer, Aruna Mehra, Barrett H. Childs, Yuankai Shi, Pier Luigi Zinzani.
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3) : a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet. Oncology
2021 : Vol. 22, nr 5, s. 678-689, il., bibliogr. 34 poz., sum.
Autor korespondencyjny: Matthew J. Matasar.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 54.433
Adres url:
Streszczenie w PubMed:
7/20
Aneel Bhangu.
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries : an international, prospective, cohort study.
Lancet. Oncology
2021 : Vol. 22, nr 11, s. 1507-1517, il., bibliogr., sum.
Autor korespondencyjny: Aneel Bhangu
Open Access Creative Commons Attribution License CC-BY-NC-ND
Publikacja wieloośrodkowa (brak nazwiska w polu autorskim)
p-ISSN: 1470-2045
AZ
IF: 54.433
Adres url:
8/20
Philippe Moreau, Shaji K. Kumar, Jesús San Miguel, Faith Davies, Elena Zamagni, Nizar Bahlis, Heinz Ludwig, Joseph Mikhael, Evangelos Terpos, Fredrik Schjesvold, Thomas Martin, Kwee Yong, Brian G.M. Durie, Thierry Facon, Artur Jurczyszyn, Surbhi Sidana, Noopur Raje, Niels van de Donk, Sagar Lonial, Michele Cavo, Sigurdur Y. Kristinsson, Suzanne Lentzsch, Roman Hajek, Kenneth C. Anderson, Cristina Joao, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt, Rafael Fonseca, Annette Vangsted, Katja Weisel, Rachid Baz, Vania Hungria, Jesus G. Berdeja, Fernando Leal da Costa, Angelo Maiolino, Anders Waage, David H. Vesole, Enrique M. Ocio, Hang Quach, Christoph Driessen, Joan Bladé, Xavier Leleu, Eloisa Riva, Peter Leif Bergsage, Jian Ho, Wee Joo Chng, Ulf-Henrik Mellqvist, Dominik Dytfeld, Jean-Luc Harousseau, Hartmut Goldschmidt, Jacob Laubach, Nikhil C. Munshi, Francesca Gay, Meral Beksac, Luciano J. Costa, Martin Kaiser, Parameswaran Hari, Mario Boccadoro, Saad Z. Usmani, Sonja Zweegman, Sarah Holstein, Orhan Sezer, Simon Harrison, Hareth Nahi, Gordon Cook, Maria-victoria Mateos, S. Vincent Rajkumar, Meletios A. Dimopoulos, Paul G. Richardson.
Treatment of relapsed and refractory multiple myeloma : recommendations from the International Myeloma Working Group.
Lancet. Oncology
2021 : Vol. 22, nr 3, s. e105-e118, il., bibliogr. 66 poz.
Autor korespondencyjny: Philippe Moreau.
p-ISSN: 1470-2045
AZ
POG
AIF
IF: 54.433
Adres url:
Streszczenie w PubMed:
9/20
Gilles Salles, Johannes Duell, Eva González Barca, Olivier Tournilhac, Wojciech Jurczak, Anna Marina Liberati, Zsolt Nagy, Ale Obr, Gianluca Gaidano, Marc André, Nagesh Kalakonda, Martin Dreyling, Johannes Weirather, Maren Dirnberger-Hertweck, Sumeet Ambarkhane, Günter Fingerle-Rowson, Kami Maddocks.
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND) : a multicentre, prospective, single-arm, phase 2 study.
Lancet. Oncology
2020 : Vol. 21, nr 7, s. 978-988, il., bibliogr. 30 poz., sum.
Autor korespondencyjny: Gilles Salles.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 41.316
Adres url:
Streszczenie w PubMed:
10/20
Franck Morschhauser, Herve Tilly, Aristeidis Chaidos, Pamela McKay, Tycel Phillips, Sarit Assouline, Connie Lee Batlevi, Phillip Campbell, Vincent Ribrag, Gandhi Laurent Damaj, Michael Dickinson, Wojciech Jurczak, Maciej Kazmierczak, Stephen Opat, John Radford, Anna Schmitt, Jay Yang, Jennifer Whalen, Shefali Agarwal, Deyaa Adib, Gilles Salles.
Tazemetostat for patients with relapsed or refractory follicular lymphoma : an open-label, single-arm, multicentre, phase 2 trial.
Lancet. Oncology
2020 : Vol. 21, nr 11, s. 1433-1442, il., bibliogr. 30 poz., sum.
Autor korespondencyjny: Franck Morschhauser.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 41.316
Adres url:
Streszczenie w PubMed:
11/20
Ruth Ladenstein, Ulrike Pötschger, Andrew D.J. Pearson, Penelope Brock, Roberto Luksch, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Genevieve Laureys, Josef Malis, Walentyna Balwierz, Ellen Ruud, Per Kogner, Henrik Schroeder, Ana Forjaz De Lacerda, Maja Beck-Popovic, Pavel Bician, Miklós Garami, Toby Trahair, Adela Canete, Peter F. Ambros, Keith Holmes, Mark Gaze, Günter Schreier, Alberto Garaventa, Gilles Vassal, Jean Michon, Dominique Valteau-Couanet.
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.
Lancet. Oncology
2017 : Vol. 18, nr 4, s. 500-514, il., bibliogr. 30 poz., sum.
Autor korespondencyjny: Ruth Ladenstein.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 36.418
Adres url:
Streszczenie w PubMed:
12/20
Andrew D. Zelenetz, Jacqueline C. Barrientos, Jennifer R. Brown, Bertrand Coiffier, Julio Delgado, Miklós Egyed, Paolo Ghia, Árpad Illes, Wojciech Jurczak, Paula Marlton, Marco Montillo, Franck Morschhauser, Alexander S. Pristupa, Tadeusz Robak, Jeff P. Sharman, David Simpson, Lukas Smolej, Eugen Tausch, Adeboye H. Adewoye, Lyndah K. Dreiling, Yeonhee Kim, Stephan Stilgenbauer, Peter Hillmen.
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet. Oncology
2017 : Vol. 18, nr 3, s. 297-311, il., bibliogr. 22 poz., sum.
Autor korespondencyjny: Andrew D. Zelenetz.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 36.418
Adres url:
Streszczenie w PubMed:
13/20
Meletios A. Dimopoulos, Philippe Moreau, Antonio Palumbo, Douglas Joshua, Ludek Pour, Roman Hajek, Thierry Facon, Heinz Ludwig, Albert Oriol, Hartmut Goldschmidt, Laura Rosinol, Jan Straub, Aleksandr Suvorov, Carla Araujo, Elena Rimashevskaya, Tomas Pika, Gianluca Gaidano, Katja Weisel, Vesselina Goranova-Marinova, Anthony Schwarer, Leonard Minuk, Tamas Masszi, Ievgenii Karamanesht, Massimo Offidani, Vania Hungria, Andrew Spencer, Robert Z. Orlowski, Heidi H. Gillenwater, Nehal Mohamed, Shibao Feng, Wee-Joo Chng, ENDEAVOR investigators.
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Lancet. Oncology
2016 : Vol. 17, nr1, s. 27-38, il., bibliogr. 23 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 33.900
Adres url:
Streszczenie w PubMed:
14/20
Asher Chanan-Khan, Paula Cramer, Fatih Demirkan, Graeme Fraser, Rodrigo Santucci Silva, Sebastian Grosicki, Aleksander Pristupa, Ann Janssens, Jiri Mayer, Nancy L. Bartlett, Marie-Sarah Dilhuydy, Halyna Pylypenko, Javier Loscertales, Abraham Avigdor, Simon Rule, Diego Villa, Olga Samoilova, Panagiots Panagiotidis, Andre Goy, Anthony Mato, Miguel A. Pavlovsky, Claes Karlsson, Michelle Mahler, Mariya Salman, Steven Sun, Charles Phelps, Sriram Balasubramanian, Angela Howes, Michael Hallek, HELIOS investigators.
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
Lancet. Oncology
2016 : Vol. 17, nr 2, s. 200-211, il., bibliogr. 22 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 33.900
Adres url:
15/20
Marek Trneny, Thierry Lamy, Jan Walewski, David Belada, Jiri Mayer, John Radford, Wojciech Jurczak, Franck Morschhauser, Julia Alexeeva, Simon Rule, Boris Afanasyev, Kamil Kaplanov, Antoine Thyss, Alexej Kuzmin, Sergey Voloshin, Kazimierz Kuliczkowski, Agnieszka Giza, Noel Milpied, Caterina Stelitano, Reinhard Marks, Lorenz Trumper, Tsvetan Biyukov, Meera Patturajan, Marie-Laure Casadebaig Bravo, Casadebaig Bravo, Luca Arcaini.
Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial.
Lancet. Oncology
2016 : Vol. 17, nr 3, s. 319-331, il., bibliogr. 28 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 33.900
Adres url:
Streszczenie w PubMed:
16/20
Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, Steven Coutre, John F. Seymour, Talha Munir, Soham D. Puvvada, Clemens-Martin Wendtner, Andrew W. Roberts, Wojciech Jurczak, Stephen P. Mulligan, Sebastian Böttcher, Mehrdad Mobasher, Ming Zhu, Monali Desai, Brenda Chyla, Maria Verdugo, Sari Heitner Enschede, Elisa Cerri, Rod Humerickhouse, Gary Gordon, Michael Hallek, William G. Wierda.
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
Lancet. Oncology
2016 : Vol. 17, nr 6, s. 768-778, il., bibliogr. 30 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 33.900
Adres url:
Streszczenie w PubMed:
17/20
Frederic Castinetti, Xiao-Ping Qi, Martin K. Walz, Ana Luiza Maia, Gabriela Sanso, Mariola Peczkowska, Kornelia Hasse-Lazar, Thera P. Links, Sarka Dvorakova, Rodrigo A. Toledo, Caterina Mian, Maria Joao Bugalho, Nelson Wohllk, Oleg Kollyukh, Letizia Canu, Paola Loli, Simona R. Bergmann, Josefina Biarnes Costa, Ozer Makay, Attila Patocs, Marija Pfeifer, Nalini S. Shah, Thomas Cuny, Michael Brauckhoff, Birke Bausch, Ernst von Dobschuetz, Claudio Letizia, Marcin Barczynski, Maria K. Alevizaki, Malgorzata Czetwertynska, M. Umit Ugurlu, Gerlof Valk, John T. M. Plukker, Paola Sartorato, Debora R. Siqueira, Marta Barontini, Malgorzata Szperl, Barbara Jarzab, Hans H.G. Verbeek, Tomas Zelinka, Petr Vlcek, Sergio P.A. Toledo, Flavia L. Coutinho, Massimo Mannelli, Monica Recasens, Lea Demarquet, Luigi Petramala, Svetlana Yaremchuk, Dmitry Zabolotnyi, Francesca Schiavi, Giuseppe Opocher, Karoly Racz, Andrzej Januszewicz, Georges Weryha, Jean-Francois Henry, Thierry Brue, Bernard Conte-Devolx, Charis Eng, Hartmut P.H. Neumann.
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study.
Lancet. Oncology
2014 : Vol. 15, nr 6, s. 648-655, il., bibliogr. 19 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 24.690
18/20
Meredith M. Regan, Patrick Neven, Anita Giobbie-Hurder, Aron Goldhirsch, Bent Ejlertsen, Louis Mauriac, John F. Forbes, Ian Smith, Istvan Lang, Andrew Wardley, Manuela Rabaglio, Karen N. Price, Richard D. Gelber, Alan S. Coates, Beat Thurlimann, BIG 1-98 Collaborative Group, International Breast Cancer Study Group (IBCSG).
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8ˇ1 years median follow-up.
Lancet. Oncology
2011 : Vol. 12, nr 12, s. 1101-1108, il., bibliogr. 23 poz.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 22.589
19/20
Bertrand Coiffier, Evgenii A. Osmanov, Xiaonan Hong, Adriana Scheliga, Jiri Mayer, Fritz Offner, Simon Rule, Adriana Teixeira, Jan Walewski, Sven Vos, de, Michael Crump, Ofer Shpilberg, Dixie-Lee Esseltine, Eugene Zhu, Christopher Enny, Panteli Theocharous, Helgi Velde, van de, Yusri A. Elsayed, Pier Luigi Zinzani, LYM-3001 study investigators.
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma : a randomised phase 3 trial.
Lancet. Oncology
2011 : Vol. 12, nr 8, s. 773-784, il., bibliogr. 44 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 22.589
20/20
Peter Kenemans, Nigel J. Bundred, Jean-Michel Foidart, Ernst Kubista, Bo von Schoultz, Piero Sismondi, Rena Vassilopoulou-Sellin, Cheng Har Yip, Jan Egberts, Mirjam Mol-Arts, Roel Mulder, Steve van Os, Matthias W. Beckmann, the LIBERATE Study Group.
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms : a double-blind, randomised, non-inferiority trial.
Lancet. Oncology
2009 : Vol. 10, nr 2, s. 135-146, il., bibliogr. 30 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 14.470
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ